Singh, Chandramani
Verma, Savita
Reddy, Prabhakar
Diamond, Michael S. http://orcid.org/0000-0002-8791-3165
Curiel, David T. http://orcid.org/0000-0003-3802-6014
Patel, Chintan
Jain, Manish Kumar
Redkar, Sagar Vivek
Bhate, Amit Suresh
Gundappa, Vivek http://orcid.org/0000-0002-3644-3765
Konatham, Rambabu
Toppo, Leelabati
Joshi, Aniket Chandrakant
Kushwaha, Jitendra Singh
Singh, Ajit Pratap
Bawankule, Shilpa
Ella, Raches
Prasad, Sai
Ganneru, Brunda
Chiteti, Siddharth Reddy
Kataram, Sreenivas
Vadrevu, Krishna Mohan
Funding for this research was provided by:
Department of Biotechnology, Ministry of Science and Technology (BT/CS0019/CS/01/20 Dt.12.04.2021)
Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Govt. of India.
Article History
Received: 14 April 2023
Accepted: 1 August 2023
First Online: 18 August 2023
Competing interests
: The principal investigators were C.S., S.V., P.R., C.P., M.K.J., S.V.R., A.S.B., V.G., R.K., L.T., A.C.J., J.S.K., A.P.S. and S.B. B.G., S. Re., K.S., R.E., S. Pr, and K.M.V. are employees of Bharat Biotech, with no stock options or incentives. M.S.D. is a consultant for Inbios, Vir Biotechnology, Senda Biosciences, Moderna, and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Emergent BioSolutions, and Moderna. M.S.D. and Washington University School of Medicine developed the SARS-CoV-2 ChAd vaccine that was licensed to Bharat Biotech for commercial development, and as such could receive royalty payments.